WASHINGTON, D.C. — Federal regulators are moving to reduce the use of animal testing in drug development, issuing new ...
Non-animal testing methods could save drugmakers time and money, officials say ...
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
IRVINE, CA, UNITED STATES, March 17, 2026 /EINPresswire.com/ — Qalitex Laboratories, an ISO 17025-accredited third-party analytical testing laboratory serving pharmaceutical developers, contract ...